Including Reagent Preparation Patents (Class 436/166)
  • Patent number: 7655474
    Abstract: A method of making a nanoclusters functionalized with a single DNA strand comprising the steps of providing nanoclusters, combining said nanoclusters with thiolated DNA, incubating said nanoclusters and thiolated DNA mixture, combining said mixture with a solution comprising ethanol and dichloromethane; separating said mixture into an aqueous phase and an organic phase, mixing said aqueous phase with a solution comprising dicholormethane and NaCl, and separating the mixture into an aqueous phase and an organic phase; wherein said organic phase comprises said nanoclusters functionalized with a single DNA strand. Further, provided is a nanocluster functionalized with a single DNA strand comprising a nanocluster, said nanocluster being functionalized with a single DNA strand, said DNA strand having a length of about 10 to about 50 bases.
    Type: Grant
    Filed: April 3, 2006
    Date of Patent: February 2, 2010
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Sulay Jhaveri, Mario Ancona, Edward E Foos, Eddie L Chang
  • Patent number: 7651864
    Abstract: A method of preparing a coating solution for a glucose sensing membrane, the method comprising preserving a first solution containing an oxidizing enzyme or a reducing enzyme of glucose and a reagent for generating a substance for coloring a coloring agent dissolved in a buffer solution, preserving a second solution containing a mixed solution of an alcohol solution of the coloring agent and a solution of a membrane-forming polymer compound, and mixing the first solution and the second solution.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: January 26, 2010
    Assignee: Kabushiki Kaisha Toshiba
    Inventors: Shingo Kasai, Kayoko Oomiya, Ikuo Uematsu, Ichiro Tono
  • Patent number: 7648826
    Abstract: This invention pertains to the discovery that an amplification of the CYP24 gene or an increase in CYP24 activity is a marker for the presence of, progression of, or predisposition to, a cancer (e.g., breast cancer). Using this information, this invention provides methods of detecting a predisposition to cancer in an animal. The methods involve (i) providing a biological sample from an animal (e.g. a human patient); (ii) detecting the level of CYP24 within the biological sample; and (iii) comparing the level of CYP24 with a level of CYP24 in a control sample taken from a normal, cancer-free tissue where an increased level of CYP24 in the biological sample compared to the level of CYP24 in the control sample indicates the presence of said cancer in said animal.
    Type: Grant
    Filed: April 2, 1999
    Date of Patent: January 19, 2010
    Assignee: The Regents of the University of California
    Inventors: Donna G. Albertson, Daniel Pinkel, Colin Collins, Joe W. Gray, Bauke Ystra
  • Patent number: 7648841
    Abstract: The present invention relates to a reagent for determining the absolute configuration of a chiral compound containing as an active ingredient a metalloporphyrin dimer, wherein the metalloporphyrin dimer has an alkaline-earth metal ion as a central metal and has a carbon chain-crosslinked structure in which at least one of the two porphyrin rings has a substituent bulkier than methyl at least one of the second carbon atoms from a carbon atom bonded to the crosslinking carbon chain along the outer periphery of the porphyrin ring and a method for determining the absolute configuration of an asymmetric carbon atom of the chiral compound using the reagent.
    Type: Grant
    Filed: January 10, 2003
    Date of Patent: January 19, 2010
    Assignee: Japan Science and Technology Agency
    Inventors: Yoshihisa Inoue, Victor Borovkov, Juha Lintuluoto
  • Publication number: 20100009458
    Abstract: A sensor-chip includes a sensor-portion having at least a metal-layer deposited on a surface of a dielectric-plate. A fluorescent-label binding-substance in an amount corresponding to the amount of a detection-target-substance in a liquid-sample binds onto the sensor-portion. The amount of the detection-target-substance is detected based on the amount of light generated by excitation of a fluorescent-label in the fluorescent-label binding-substance. A fluorescent-substance the charge state of which changes in the liquid-sample according to the pH of the liquid-sample, and which contains a plurality of fluorescent-dye-molecules enclosed by a material that transmits fluorescence output from the fluorescent-dye-molecules, is used as the fluorescent-label.
    Type: Application
    Filed: July 13, 2009
    Publication date: January 14, 2010
    Applicant: FUJIFILM Corporation
    Inventor: Hisashi Ohtsuka
  • Patent number: 7638092
    Abstract: An artificial lipid bilayer membrane formation device is disclosed, which includes: an upper solution chamber (first solution chamber) and a lower solution chamber (second solution chamber), both of which are filled with aqueous solution. It further includes a partition wall disposed between the upper solution chamber and the lower solution chamber so as to part the upper and lower solution chambers from each other. The partition wall has an opening, and a first lipid solution is applied to a portion around the opening, thereby forming an artificial lipid bilayer membrane on the opening. Further, in the formation device, a tubule for lipid substitution is attached to the partition wall so as to be positioned on a bulk phase of the artificial lipid bilayer membrane. A second lipid solution is added via the tubule, thereby forming an artificial lipid bilayer membrane whose lipid composition is changed.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: December 29, 2009
    Assignee: Japan Science and Technology Agency
    Inventor: Toru Ide
  • Patent number: 7635596
    Abstract: A method for monitoring degradation of lubricating oils. The method comprises steps of: (a) adding to a lubricating oil at least one compound having formula (I) wherein R1 and R2 independently are hydrogen, hydroxy, OR11, amino or NR11R12; R3 and R5 independently are alkyl, aryl, aralkyl, heteroalkyl or heterocyclic; R4 and R6 independently are hydrogen or alkyl; R7, R8, R9 and R10 independently are cyano, nitro, amide, carboxyl, ester, alkyl or hydrogen; R11 is alkyl, aryl, aralkyl, heteroalkyl, heterocyclic or alkanoyl; R12 is hydrogen or alkyl; provided that said at least one compound of formula (I) has at least one substituent selected from among cyano, nitro, hydroxy, hydroxyalkyl, amide, carboxyl, ester and unsaturated alkyl; and (b) measuring a spectroscopic property of the oil to determine degradation of said at least one compound.
    Type: Grant
    Filed: November 8, 2005
    Date of Patent: December 22, 2009
    Assignee: Rohm and Haas Company
    Inventors: Rajiv Manohar Banavali, Kim Sang Ho
  • Publication number: 20090311796
    Abstract: An analytical device for analysis of chemical or biological samples, a method of using such a device, based on rotation of the device, integrated sample dosing and optical detection, and a system comprising such a device are disclosed. The analytical device comprises a device body having a liquid processing unit. The liquid processing unit comprises a mixing chamber for mixing a sample with a reagent, a sample dosing chamber for delivering a defined volume of the sample to the mixing chamber, and a reagent channel for delivering the reagent to be mixed with the sample, wherein the mixing chamber also serves as a detection chamber.
    Type: Application
    Filed: June 11, 2009
    Publication date: December 17, 2009
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Patrick Griss, Rainer Jaeggi, Goran Savatic, Vuk Siljegovic
  • Patent number: 7629016
    Abstract: The invention relates to a photochemical process for the preparation of an activated polymer surface having an active fluoro group using 1-fluoro-2-nitro-4-azidobenzene to form the activated polymer surface and then immobilizing a biomolecule thereon by forming a covalent bond between the activated polymer surface and the biomolecule.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: December 8, 2009
    Assignee: Council of Industrial and Scientific Research
    Inventor: Pradip Nahar
  • Patent number: 7625757
    Abstract: A reagent for analyzing immature leukocyte capable of analyzing accurately immature leukocyte such as myeloblast and immature granulocyte, and mature leukocyte, which reagent has broader allowable range of sample processing conditions than conventional ones, and a reagent kit are provided. The present invention relates to a reagent for analyzing immature leukocyte containing a surfactant for giving damage to cell membrane of red blood cell and mature leukocyte in the sample, a solubilizing agent for causing contraction to damaged blood cell, sugar, a dye for staining nucleic acid.
    Type: Grant
    Filed: January 9, 2007
    Date of Patent: December 1, 2009
    Assignee: Sysmex Corporation
    Inventors: Tomohiro Tsuji, Ayumu Yoshida, Shinichiro Oguni
  • Patent number: 7618821
    Abstract: A control and a cellular fraction for use therein and methods for making the same, including a first cellular component including a plurality of a first group of processed animal red blood cells other than human blood cells; a second cellular component including a plurality of a second group of processed animal red blood cells other than human blood cells; a third cellular component including a plurality of a third group of processed animal red blood cells other than human blood cells; wherein one or more of the first second and third cellular components include a nucleus; and the control simulates erythroblasts of a human blood sample on an automated blood analyzer that analyzes blood cells using impedance, optical measurements or both.
    Type: Grant
    Filed: April 10, 2008
    Date of Patent: November 17, 2009
    Assignee: Streck, Inc.
    Inventor: Wayne L. Ryan
  • Patent number: 7615376
    Abstract: In a process for the quantitative optical analysis of fluorescently labelled biological cells 5, a cell layer on a transparent support at the bottom 2 of a reaction vessel 1 is in contact with a solution 3 containing the fluorescent dye 4. The sensitivity of analytical detection can be considerably improved if to the fluorescent dye 4 already present in addition a masking dye 9, which absorbs the excitation light 6 for the fluorescent dye 4 and/or its emission light 7, is added to the solution 3 and/or if a separating layer 10 permeable to the solution and absorbing and/or reflecting the excitation light 6 or the emission light 7 is applied to the cell layer at the bottom 2. This process can also be used for improving the sensitivity in the quantitative optical analysis of a luminescent biological cell layer. The separating layer 10 must in this case be composed such that it has a high power of reflection for the luminescent light 11.
    Type: Grant
    Filed: August 27, 2008
    Date of Patent: November 10, 2009
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Thomas Krahn, Wolfgang Paffhausen, Andreas Schade, Martin Bechem, Delf Schmidt
  • Patent number: 7615377
    Abstract: The present invention is directed, in part, to fluorescein-based ligands for detection of metal ions, and methods of making and using the same.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: November 10, 2009
    Assignee: Massachusetts Institute of Technology
    Inventors: Stephen J. Lippard, Elizabeth Marie Nolan
  • Publication number: 20090269853
    Abstract: A method of making a nanoclusters functionalized with a single DNA strand comprising the steps of providing nanoclusters, combining said nanoclusters with thiolated DNA, incubating said nanoclusters and thiolated DNA mixture, combining said mixture with a solution comprising ethanol and dichloromethane; separating said mixture into an aqueous phase and an organic phase, mixing said aqueous phase with a solution comprising dicholormethane and NaCl, and separating the mixture into an aqueous phase and an organic phase; wherein said organic phase comprises said nanoclusters functionalized with a single DNA strand. Further, provided is a nanocluster functionalized with a single DNA strand comprising a nanocluster, said nanocluster being functionalized with a single DNA strand, said DNA strand having a length of about 10 to about 50 bases.
    Type: Application
    Filed: April 3, 2006
    Publication date: October 29, 2009
    Applicant: The Government of the US, as represented by the Secretarty of the Navy
    Inventors: Sulay Jhaveri, Mario Ancona, Edward E. Foos, Eddie L. Chang
  • Patent number: 7608461
    Abstract: A method for producing metal nanoparticles that when associated with an analyte material will generate an amplified SERS spectrum when the analyte material is illuminated by a light source and a spectrum is recorded. The method for preparing the metal nanoparticles comprises the steps of (i) forming a water-in-oil microemulsion comprising a bulk oil phase, a dilute water phase, and one or more surfactants, wherein the water phase comprises a transition metal ion; (ii) adding an aqueous solution comprising a mild reducing agent to the water-in-oil microemulsion; (iii) stirring the water-in-oil microemulsion and aqueous solution to initiate a reduction reaction resulting in the formation of a fine precipitate dispersed in the water-in-oil microemulsion; and (iv) separating the precipitate from the water-in-oil microemulsion.
    Type: Grant
    Filed: September 16, 2005
    Date of Patent: October 27, 2009
    Assignee: Sandia Corporation
    Inventors: Blake A. Simmons, Albert Alec Talin
  • Patent number: 7604997
    Abstract: Wipes, methods and kits useful for testing and/or removal of metal from surfaces (such as, dermal surfaces) are disclosed. Exemplar wipes, including the combination of a three-dimensionally textured absorbent support, a cationic surfactant, and a weak acid, are disclosed. In some examples, the cationic surfactant is isostearamidopropyl morpholine lactate (ISML), and the weak acid is citric acid.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: October 20, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Eric J. Esswein, Mark F. Boeniger, Kevin E. Ashley
  • Patent number: 7601539
    Abstract: A standard material that is used for judging an abnormal portion in a particle analyzer is described. The standard material comprises first standard particles to be fluorescence-stained by a fluorescence-staining treatment and second standard particles that have preliminarily contained a fluorescence dye. A method and an analyzer that can judge an abnormal portion in a particle analyzer by using such a standard material are also described.
    Type: Grant
    Filed: July 11, 2006
    Date of Patent: October 13, 2009
    Assignee: Sysmex Corporation
    Inventor: Yasunori Kawate
  • Patent number: 7598089
    Abstract: The invention provides compositions and methods for cell separation. These reagents and techniques specifically agglutinate cells via surface antigen recognition and can be used to recover rare cell types in high yield.
    Type: Grant
    Filed: April 19, 2006
    Date of Patent: October 6, 2009
    Assignee: BioE, Inc.
    Inventor: Daniel P. Collins
  • Patent number: 7592182
    Abstract: Compositions and assay methods for and relating to the detection of glycated hemoglobin are provided. In particular, the presence and level of glycated hemoglobin can be detected in a blood sample. The compositions comprise microparticles which have zinc coating for use in the improved binding of proteins exhibiting a zinc binding domain, in particular glycated hemoglobin.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: September 22, 2009
    Assignee: Axis-Shield Diagnostics Limited
    Inventors: Ken Milne, Margaret Lawlor
  • Patent number: 7592179
    Abstract: The present invention provides a method for preparing a five-part differential white blood cell control and a white blood cell control prepared thereby. The white blood cell control obtained by the method of the present invention perfectly retains the light scattering properties of every type of white blood cells and has much higher stability than that of real white blood cells, and therefore can be used for the quality control of five-part differential hematology analyzers based on the principle of multi-angle light scattering.
    Type: Grant
    Filed: October 15, 2007
    Date of Patent: September 22, 2009
    Assignee: Shenzhen Mindray Bio-Medical Electronic Co., Ltd.
    Inventor: Xiaonan Guo
  • Patent number: 7588827
    Abstract: Nanoparticles, methods of preparation thereof, and methods of detecting a target molecule using embodiments of the nanoparticle, are disclosed. One embodiment of an exemplary nanoparticle, among others, includes a surface-enhanced Raman spectroscopic active composite nanostructure. The surface-enhanced Raman spectroscopic active composite nanostructure includes a core, at least one reporter molecule, and an encapsulating material. The reporter molecule is bonded to the core. The reporter molecule is selected from: an isothiocyanate dye, a multi-sulfur organic dye, a multi-heterosulfur organic dye, a benzotriazole dye, and combinations thereof. The encapsulating material is disposed over the core and the reporter molecule. After encapsulation with the encapsulating material, the reporter molecule has a measurable surface-enhanced Raman spectroscopic signature.
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: September 15, 2009
    Assignee: Emory University
    Inventors: Shuming Nie, William Doering
  • Patent number: 7582487
    Abstract: Methods and devices are provided for controlling a fluid flow over a sensing surface within a flow cell. The methods employ laminar flow techniques to position a fluid flow over one or more discrete sensing areas on the sensing surface of the flow cell. Such methods permit selective sensitization of the discrete sensing areas, and provide selective contact of the discrete sensing areas with a sample fluid flow. Immobilization of a ligand upon the discrete sensing area, followed by selective contact with an analyte contained within the sample fluid flow, allows analysis by a wide variety of techniques. Sensitized sensing surfaces, and sensor devices and systems are also provided.
    Type: Grant
    Filed: December 6, 2005
    Date of Patent: September 1, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Magnus Malmqvist, Håkan Roos, Stefan Sjölander, Mattias Tidare, Håkan Sjödin, Ralph Stålberg
  • Patent number: 7572642
    Abstract: The invention provides a particle comprising a surface, wherein a portion of the surface is capable of emitting electromagnetic radiation and another portion of the surface is capable of emitting a differential electromagnetic radiation (either different intensity, different frequency or no radiation), and wherein the arrangement of said portions of the surface defines a spatially distributed code for identifying the particle. The invention also provides method of manufacturing a particle having an identifying code comprising providing a particle with a functionalized surface which comprises functional binding moieties and selectively removing a plurality of the functional binding moieties from the surface to create a pattern of functionalized and differentially-functionalized zones on the surface. Various liquid-based assay methods employing the particle of the invention and a kit comprising the particle of the invention are also disclosed.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: August 11, 2009
    Assignee: Ambrigen, LLC
    Inventors: Nigel G. Skinner, Paul Fenton, George A. Adaniya
  • Patent number: 7563621
    Abstract: A method of applying an organic acid reagent having limited transolubility in organic solvents, aqueous solvents, and mixtures thereof to a component of a diagnostic test device by mixing an organic acid reagent and an amine to form a salt complex, dissolving the salt complex in a solvent to release the organic acid reagent into the solvent, and applying the solvent to the component of the diagnostic test device such that the organic acid reagent present in the solvent becomes integrated into the diagnostic test device. The amine is represented by the formula HmNRn wherein m is 0, 1, or 2; n is 1, 2, or 3; the sum of m and n is 3; and R is an independently selected group which renders the salt complex soluble in aqueous solvents, organic solvents, or mixtures thereof. The amine is also represented by the formula NR4+ wherein R is an independently selected group which renders the salt complex soluble in aqueous solvents, organic solvents, or mixtures thereof.
    Type: Grant
    Filed: February 17, 2003
    Date of Patent: July 21, 2009
    Assignee: Siemens Healhcare Diagnostics Inc
    Inventors: James A Profitt, Alexander H. Orn
  • Patent number: 7560284
    Abstract: Fine particles whose excitation light is not UV light or the like which has negative effects on a subject to be analyzed. The excitation light is emitted stably, and has excellent light emitting efficiency. Also a fluorescent probe including: fine particles containing a rare earth element excited by light having a wavelength in a range of 500 nm to 2000 nm and thereby emit up-conversion emission; and a specific binding substance which binds to the fine particles containing a rare earth element.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: July 14, 2009
    Assignee: Dai Nippon Printing Co., Ltd.
    Inventors: Daisuke Matsuura, Hideshi Hattori
  • Publication number: 20090155923
    Abstract: The invention relates to a mixing container (1) for a photometric measuring device, comprising a closing element (2) that can be removed from a filling hole (3) and a first liquid (5) which is located in the interior (4) of the mixing container (1), with the mixing container (1) comprising a dosing element (8) which can be placed on the filling hole (3) of the mixing container (1) after removing the closing element (2) and adding a sample liquid, and with the dosing element (8) containing a second liquid (13) in a closed hollow space (9). In accordance with the invention, the hollow space (9) in the dosing element (8) is closed by a movable plug (10) which is discharged into the interior of the mixing container (1) along with the second liquid (13) once the second liquid (13) has been subjected to pressurization.
    Type: Application
    Filed: November 8, 2006
    Publication date: June 18, 2009
    Inventor: Gerhard Bonecker
  • Patent number: 7547552
    Abstract: The present invention provides an indicator composition for evaluating cleaning of a medical instrument that includes an extracellular matrix component and hemoglobin, as a contamination model having cleaning profile resembling an actual contaminant adhered to a medical instrument such as a surgical instrument.
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: June 16, 2009
    Assignee: AMTEC Co., Ltd.
    Inventors: Mikio Doi, Shigeru Ura
  • Patent number: 7547556
    Abstract: A method and an array filling system for loading a plurality of disparate sample containers, the sample containers comprising an integral structure. Each receptacle is characterized by a hydrophilic surface, and the receptacles are separated by a hydrophobic surface. The system has a liquid transfer device capable of holding liquid and adapted for motion to cause sequential communication of liquid held in the liquid transfer device with successive receptacles of the array by dragging the liquid across the hydrophobic surface.
    Type: Grant
    Filed: October 5, 2004
    Date of Patent: June 16, 2009
    Assignee: Massachusetts Institute of Technology
    Inventors: Ian Hunter, Colin J. H. Brenan, Tanya S. Kanigan
  • Patent number: 7547441
    Abstract: A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises PAI-2 or a functional derivative, homologue, analogue, chemical equivalent or mimetic thereof, which PAI-2 is bound, linked, or otherwise associated with a toxin or label.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: June 16, 2009
    Assignees: PAI-2 Pty Limited, University of Wollongong, Medical Scitec Australia Pty Ltd
    Inventors: Marie Ranson, Barry John Allen, Clive Leighton Bunn
  • Patent number: 7544518
    Abstract: Analytical reagents and mass spectrometry-based methods using these reagents for the rapid, and quantitative analysis of proteins or protein function in mixtures of proteins. The methods employ affinity labeled protein reactive reagents having three portions: an affinity label (A) covalently linked to a protein reactive group (PRG) through a linker group (L). The linker may be differentially isotopically labeled, e.g., by substitution of one or more atoms in the linker with a stable isotope thereof. These reagents allow for the selective isolation of peptide fragments or the products of reaction with a given protein (e.g., products of enzymatic reaction) from complex mixtures. The isolated peptide fragments or reaction products are characteristic of the presence of a protein or the presence of a protein function in those mixtures. Isolated peptides or reaction products are characterized by mass spectrometric (MS) techniques.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: June 9, 2009
    Assignee: University of Washington
    Inventors: Rudolf Hans Aebersold, Michael H. Gelb, Steven P. Gygi, C. Ronald Scott, Frantisek Turecek, Scott A. Gerber, Beate Rist
  • Patent number: 7544517
    Abstract: Reagents for determining presence or concentration of cyanuric acid are described. The reagents include an indicator, a 2,4-diamino-6-alkyl-1,3,5-triazine, caffeine, which acts as a stabilizer, and may include an antioxidant.
    Type: Grant
    Filed: November 16, 2005
    Date of Patent: June 9, 2009
    Assignee: Taylor Technologies, Inc.
    Inventors: Steven M. Bacon, Jimmie L. P. Melton, Indranee C. Kuruppunayake
  • Patent number: 7544516
    Abstract: A method for determination of calcium in a sample derived from a living body, by the reaction of calcium in the sample with Chlorophosphonazo-III or a compound analogous thereto in the presence of vanadate ions, followed by determination of calcium in the sample on the basis of an optical change caused by the reaction product, is excellent in various respects as follows: it is free from the problem of absorption of carbonic acid gas caused by a high pH; it is free from the problem of use of a toxic reagent containing arsenic; it makes it possible to subject a large number of samples to determination in a short time because it can be applied to an autoanalyzer; and it permits determination in a wide range because of low sample blank values.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: June 9, 2009
    Assignee: Nitto Boseki Co., Ltd.
    Inventors: Kenta Noda, Ryo Kojima, Katsuhiro Katayama
  • Publication number: 20090136931
    Abstract: A rare-earth fluorescent complex which forms a fluorescent complex with two or more rare-earth metals such as europium and terbium and can effectively be excited at a wavelength of 340 nm or longer; a fluorescent labeling agent comprising the rare-earth fluorescent complex; a method of fluorescent labeling in which the rare-earth fluorescent complex is used as a labeling agent; and a method of fluorometric analysis in which the fluorescent labeling agent is used. The rare-earth fluorescent complex is characterized by having a cyclic ligand comprising a 4-biphenyl-2,2?:6?,2?-terpyridine skeleton and a 2,6-bis(3?-aminomethyl-1?-pyrazolyl)pyrazine skeleton bonded thereto.
    Type: Application
    Filed: August 31, 2006
    Publication date: May 28, 2009
    Applicant: Japan Science and Technology Agency
    Inventors: Kazuko Matsumoto, Takuya Nishioka, Masahito Miyabe
  • Patent number: 7533586
    Abstract: The present invention comprises an apparatus and a method for mass analyses of an array of samples contained in distinct sample holders. The sample holders are placed on a plurality of sensors which preferably comprise an array of microbalances providing output signals comprising mass data on the array of samples.
    Type: Grant
    Filed: October 4, 2005
    Date of Patent: May 19, 2009
    Assignee: UOP LLC
    Inventors: Rune Wendelbo, Duncan E. Akporiaye, Arne Karlsson, Ib-Rune Johansen, Ivar M. Dahl, Britta G. Fismen, Richard Blom, Dag T. Wang, Morten Gulliksen, Martin Plassen
  • Patent number: 7533587
    Abstract: The present invention comprises an apparatus and a method for mass analyses of an array of samples contained in distinct sample holders. The sample holders are placed on a plurality of sensors which preferably comprise an array of microbalances providing output signals comprising mass data on the array of samples.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: May 19, 2009
    Assignee: UOP LLC
    Inventors: Rune Wendelbo, Duncan E. Akporiaye, Arne Karlsson, Ib-Rune Johansen, Ivar M. Dahl, Britta G. Fismen, Richard Blom, Dag T. Wang, Morten Gulliksen, Martin Plassen
  • Publication number: 20090124021
    Abstract: The invention relates to a device for containing, reacting and measuring, and a method of containing, reacting and measuring, and provides a device for containing, reacting and measuring, and a method of containing, reacting and measuring which is also able to effectively and quickly perform the reaction processing, measuring and identification.
    Type: Application
    Filed: January 13, 2009
    Publication date: May 14, 2009
    Applicant: PSS BIO INSTRUMENTS, INC.
    Inventor: Hideji Tajima
  • Patent number: 7531111
    Abstract: A visual indicating paste for detecting the level of hydrocarbons in a storage container is disclosed. The visual indicating paste is a physical mixture of a non-polar dye, a high molecular weight carrier, a whitening agent and a filler material.
    Type: Grant
    Filed: February 8, 2007
    Date of Patent: May 12, 2009
    Inventor: Nabil J. Mohtadi
  • Patent number: 7531362
    Abstract: An improved rapid diagnostic device, assay and multifunctional buffer reagent are provided for the detection of a target analyte in a fluid test sample. The 2-step assay utilizes a dual component flow-through device comprising a test unit and a post-filter unit capable of receiving the fluid sample and multifunctional buffer, respectively. The test unit comprises a reaction zone containing immobilized capture reagent that can specifically bind to the target analyte, an absorbent zone supporting the reaction zone, and optionally, a blood separation zone in lateral fluid communication with the reaction zone. The post-filter unit comprises a label zone permeated with a dried indicator reagent which is capable of being placed in transient fluid communication with the reaction zone of the test unit during the assay procedure. The rapid diagnostic assay system reduces the number of assay reagents, method steps and time required for performance compared to other conventional assays.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: May 12, 2009
    Assignee: MedMira Inc.
    Inventor: Hermes K. W. Chan
  • Patent number: 7514265
    Abstract: The present application describes a reagent system for detecting presence of aldehyde in a sample that includes (i) Component A, which includes bisulfite, pararosalinine, and hydrochloric acid; and (ii) Component B, which includes a solution of hydroxide, wherein the Component A has a pH of from about 1.4 to 1.6.
    Type: Grant
    Filed: October 5, 2004
    Date of Patent: April 7, 2009
    Assignee: Marine Products Tech
    Inventors: Min Jin Yoon, Joong Cheol Lee, Yang Seo Ku
  • Patent number: 7510879
    Abstract: Described are determination procedures for fibrinogen and/or fibrinogen-derivatives by matrix-independent turbidimetry. In the FIFTA called procedure the fibrinogen activity is preferably determined in an undiluted sample by addition of thrombin and/or albumin, as well as polybrene if appropriate, in PBS and determination of the increase in absorbance at 405 nm. In the FIATA called procedure the fibrinogen-concentration and/or the concentration of fibrinogen-derivatives is preferably determined by addition of vancomycin and determination of the increase in turbidity at 405 nm. It is standardized by usage of plasma standards of known fibrinogen-activity and/or fibrinogen-concentration.
    Type: Grant
    Filed: June 2, 2004
    Date of Patent: March 31, 2009
    Inventor: Thomas W. Stief
  • Patent number: 7504264
    Abstract: A method for characterizing highly parallelized liquid handling technology using microplates and test kit for carrying out the method. Possibilities for characterizing a multi-channel or many-channel handling technology are known in principle. However, especially with regard to more highly parallelized devices and very small volumes, particularly under conditions corresponding to the actual application conditions, these possibilities were relatively expensive and presented problems especially with respect to the accuracy of evaluation and with respect to correctness and precision. The present method enables a more economical and very exact characterization for applications of this kind.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: March 17, 2009
    Assignee: CyBio AG
    Inventors: Heidrun Rhode, Barbara Horn, legal representative, Margarete Schulze, Gerhard Cumme, Anton Horn
  • Publication number: 20090053823
    Abstract: A liquid reagent in which a methylene blue compound color former is stably stored in a liquid state; and a method of stabilizing a methylene blue compound color former in a liquid state. A methylene blue compound color former is stabilized by causing it to coexist with either a quaternary ammonium compound having a C12 or higher hydrocarbon chain or a salt thereof in a liquid medium. Examples of the methylene blue compound color former include 10-(carboxymethylaminocarbonyl)-3,7-bis(dimethylamino) phenothiazine.
    Type: Application
    Filed: January 18, 2007
    Publication date: February 26, 2009
    Applicant: ARKRAY, Inc.
    Inventors: Satoshi Yonehara, Norio Inamura
  • Patent number: 7491542
    Abstract: The present invention provides a test device for determining the concentration of LDL-cholesterol in a sample. The test device has a continuous solid surface with at least one reaction area on the continuous solid surface, and the reaction area has, in dry form, a non-LDL inhibitor and a system for determining the concentration of cholesterol.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: February 17, 2009
    Inventor: Kim Scheuringer
  • Patent number: 7491545
    Abstract: A highly selective and sensitive of a carbonic anhydrase-based method for measurement of zinc ion by an excitation ratiometric format based on resonance energy transfer: i.e., where the zinc ion level is transduced as the ratio of fluorescence intensities excited at two different excitation wavelengths, is provided. The method can be used very well in a fluorescence microscopy format. A detection limit of about 10 pM in zinc buffered systems, a ten to one thousand-fold improvement on the Fura indicators (which respond to Ca and Mg as well), and a one hundred thousand-fold improvement on the recently described FuraZin-1 is achieved.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: February 17, 2009
    Inventors: Richard Thompson, Michele Cramer, Carol Ann Fierke, Hui Hui Zeng, Rebecca Bozym
  • Publication number: 20090004753
    Abstract: The present disclosure is directed to a reactive ester agent capable of conjugating a reporter molecule to a carrier molecule or solid support. The reactive ester agent has the general formula: wherein the variables are described throughout the application.
    Type: Application
    Filed: January 30, 2008
    Publication date: January 1, 2009
    Applicant: INVITROGEN CORPORATION
    Inventors: Evan Antoulinakis, Diane M. Witczak, Kyle Gee, Aleksey Rukavishnikov
  • Publication number: 20080318336
    Abstract: The present invention relates to labels capable of forming a covalent or non-covalent bond with a target molecule, consisting of a dye to which there is bonded in a covalent manner by one or more carbons of its chemical structure: one or more [FUNC] group(s), and optionally one or more [SOL] group(s), said label having the general formula: [DYE] representing the dye; [FUNC] each independently representing an -X-A-Z group, in which: X is chosen from the group consisting of an oxygen atom, a sulphur atom, an NR1R2 group, R1 and R2 each being independently of each other a hydrogen atom or a linear or branched C1-C30, preferably C1-C18 and more preferentially C1-C5 alkyl group; A is chosen from the group consisting of an alkylene group or an alkylene-arylene group; Z is a reactive chemical function; [SOL] each independently representing an -X?-A?-Z? group, in which: X? is chosen from the group consisting of an oxygen atom, a sulphur atom, an NR1R2 group, R1 and R2 each being independently of ea
    Type: Application
    Filed: August 11, 2006
    Publication date: December 25, 2008
    Applicant: Laboratoires Synth-Innove
    Inventors: Francois Scherninski, Vincent Guyon, Marie-Noelle Rager
  • Publication number: 20080293153
    Abstract: A method of photofragmentation is provided comprising: providing a masked fluorescent molecule having a masking group bonded to a fluorescent molecule through a photolabile covalent bond; exposing the masked fluorescent molecule to cleaving photoradiation, producing an unmasked fluorescent molecule; detecting the fluorescence of the unmasked fluorescent molecule. The photolabile covalent bond disrupts the conjugation of the fluorescent molecule, causing the fluorescence to be masked. When the photolabile covalent bond is broken, the conjugation is restored, resulting in an increase in fluorescence of the fluorescent molecule as compared to the masked fluorescent molecule.
    Type: Application
    Filed: June 30, 2006
    Publication date: November 27, 2008
    Inventors: Andrei G. Kutateladze, Alexei Kurchan, Rudresha Kottani, Janaki Majjigapu
  • Publication number: 20080286880
    Abstract: Methods and systems for utilizing metal nanoparticles to enhance optical (UV, visible, and IR, as appropriate) signals from a reporting entity are presented. The methods and systems of this invention do not require the nanoparticles to be attached or adhered to a surface, assembled in a matrix or coated with a spacer coating.
    Type: Application
    Filed: July 5, 2005
    Publication date: November 20, 2008
    Applicant: The Penn State Research Foundation
    Inventors: Samer Al-Murrani, Stephen J. Fonash, Matthew R. Henry, Ali Kaan Kalkan, Daniel Krissinger, Terry Rager
  • Patent number: 7449146
    Abstract: Colorimetric sensor films comprising a reflective layer, a polymeric detection layer, and a semi-reflective layer are disclosed. Devices comprising the colorimetric sensor films and methods of making the films and devices are also disclosed.
    Type: Grant
    Filed: March 24, 2004
    Date of Patent: November 11, 2008
    Assignee: 3M Innovative Properties Company
    Inventors: Neal A. Rakow, Christopher S. Lyons, Stephen P. Maki
  • Patent number: 7449337
    Abstract: A lytic reagent composition and methods for differential analysis of leukocytes are disclosed. In embodiments, the analysis may utilize optical measurements in flow cytometry based hematology analyzers. The reagent system includes an anionic surfactant in a hypotonic solution, an inorganic buffer to maintain the pH in a range from about 6 to about 10, and optionally a leukocyte stabilizer. The reagent system is used to lyse red blood cells and stabilize the leukocytes to enable multi-part differentiation of leukocytes in a near physiologic pH environment on a flow cytometry based hematology analyzer using axial light loss, light scatter intensity, high-numerical aperture side scatter, and time-of-flight measurements.
    Type: Grant
    Filed: January 24, 2007
    Date of Patent: November 11, 2008
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Chiranjit Deka, Jianwen Feng